Home › Funds › GENDELL JEFFREY L › INDV

GENDELL JEFFREY L position in INDV

INDIVIOR PHARMACEUTICALS INC · Health Care

GENDELL JEFFREY L reported holding 1,146,343 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$41.1M, representing 0.43% of its reported portfolio and ranking #24 among its reported holdings. GENDELL JEFFREY L has disclosed INDV holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)1.15M sh
Reported value held$41.10M
Portfolio Weight0.43%
First reportedQ4 2024
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How GENDELL JEFFREY L's INDV position evolved

GENDELL JEFFREY L first disclosed a stake in INDV in Q4 2024 at 303,263 shares (US$3.8M). The position peaked in Q2 2026 at 1,096,343 shares, worth US$45.0M. Across 8 filings, GENDELL JEFFREY L increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,146,343 shares valued at US$41.1M — an increase of 50,000 shares quarter over quarter.. Notable position changes include a 100% increase in Q1 2025 (shares rose 55% over the following quarter), a 41% increase in Q2 2025 (shares rose 64% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 303.26K $3.77M New
Q1 2025 606.48K $5.78M Add
Q2 2025 856.48K $12.62M Add
Q3 2025 1.05M $25.23M Add
Q4 2025 1.10M $39.34M Add
Q1 2026 1.10M $33.42M Hold
Q2 2026 1.10M $44.98M Hold
Q3 2026 1.15M $41.10M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INDV and 13F data

INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INDV

All INDV fund holders →

FAQ

How long has GENDELL JEFFREY L held INDV?

GENDELL JEFFREY L has disclosed INDV holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is GENDELL JEFFREY L's current position in INDV?

As of Q3 2026, GENDELL JEFFREY L holds 1.15M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $41.10M, representing 0.43% of its reported portfolio and ranking #24.

Has GENDELL JEFFREY L been buying or selling INDV?

In the latest 13F filing (Q3 2026), GENDELL JEFFREY L increased its position in INDV. The position peaked in Q2 2026 at 1.10M shares.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.